Cited by

• Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics.

  Jaime MD, Lopez-Llorca LV, Conesa A, Lee AY, Proctor M, Heisler LE, Gebbia M, Giaever G, Westwood JT, Nislow C. Jaime MD, et al. BMC Genomics. 2012 Jun 22;13:267. doi: 10.1186/1471-2164-13-267. BMC Genomics. 2012. PMID: 22727066 Free PMC article.
• Single yeast cell nanomotions correlate with cellular activity.

  Willaert RG, Vanden Boer P, Malovichko A, Alioscha-Perez M, Radotić K, Bartolić D, Kalauzi A, Villalba MI, Sanglard D, Dietler G, Sahli H, Kasas S. Willaert RG, et al. Sci Adv. 2020 Jun 24;6(26):eaba3139. doi: 10.1126/sciadv.aba3139. eCollection 2020 Jun. Sci Adv. 2020. PMID: 32637604 Free PMC article.
• Determination of antifungal susceptibility patterns among the clinical isolates of Candida species.

  Zomorodian K, Rahimi MJ, Pakshir K, Motamedi M, Ghiasi MR, Rezashah H. Zomorodian K, et al. J Glob Infect Dis. 2011 Oct;3(4):357-60. doi: 10.4103/0974-777X.91059. J Glob Infect Dis. 2011. PMID: 22223999 Free PMC article.
• Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis.

  Santangelo R, Paderu P, Delmas G, Chen ZW, Mannino R, Zarif L, Perlin DS. Santangelo R, et al. Antimicrob Agents Chemother. 2000 Sep;44(9):2356-60. doi: 10.1128/AAC.44.9.2356-2360.2000. Antimicrob Agents Chemother. 2000. PMID: 10952579 Free PMC article.
• Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.

  Louie A, Banerjee P, Drusano GL, Shayegani M, Miller MH. Louie A, et al. Antimicrob Agents Chemother. 1999 Dec;43(12):2841-7. doi: 10.1128/AAC.43.12.2841. Antimicrob Agents Chemother. 1999. PMID: 10582869 Free PMC article.